- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Relapsing multiple sclerosis
Total 14515 results
-
BayerCompletedRelapsing-remitting Multiple SclerosisFrance
-
Teva Neuroscience, Inc.Completed
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing RemittingArgentina
-
Merck KGaA, Darmstadt, GermanyMerck Quimica Argentina S.A.I.CCompletedMultiple Sclerosis, Relapsing RemittingArgentina
-
Merck KGaA, Darmstadt, GermanyCompleted
-
University of California, San FranciscoNational Multiple Sclerosis Society; Teva Neuroscience, Inc.CompletedMultiple SclerosisUnited States
-
Nuron Biotech Inc.UnknownRelapsing Remitting Multiple SclerosisPoland, Spain, Belarus, Bulgaria, Serbia, Ukraine, Russian Federation, Hungary, Italy, Croatia, Georgia, Lebanon
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Spain
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A., GenevaCompletedMultiple Sclerosis, Relapsing-RemittingNetherlands
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
BiogenCompleted
-
BiogenCompletedRelapsing-remitting Multiple SclerosisBelgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
-
Merck KGaA, Darmstadt, GermanyMerck spol.s.r.o., Czech RepublicCompletedMultiple Sclerosis, Relapsing-RemittingCzech Republic
-
NovartisMitsubishi Tanabe Pharma CorporationCompleted
-
Teva Branded Pharmaceutical Products R&D, Inc.Withdrawn
-
EMD SeronoPfizerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)United States
-
EMD SeronoCompletedRelapsing Multiple SclerosisUnited States
-
EMD SeronoWithdrawnRelapsing-Remitting Multiple Sclerosis
-
EMD SeronoMerck Serono International SACompletedMultiple Sclerosis, Relapsing-remitting
-
EMD SeronoMerck Serono International SACompletedMultiple Sclerosis, Relapsing-Remitting
-
John F. Foley, MDBiogen; Elan PharmaceuticalsCompletedMultiple SclerosisUnited States
-
Coordinación de Investigación en Salud, MexicoCompleted
-
National Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
University of Southern CaliforniaTeva Pharmaceuticals USACompletedRelapsing Remitting Multiple SclerosisUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedMultiple Sclerosis, Relapsing-Remitting
-
SanofiCompletedMultiple SclerosisUkraine, Russian Federation, Estonia, Czech Republic, Denmark, Finland, France, Turkey, United Kingdom, United States, Portugal, Austria, Canada, Chile, Germany, Italy, Netherlands, Norway, Poland, Sweden, Switzerland
-
AlJohara M AlQuaiz, M.D.UnknownMultiple SclerosisSaudi Arabia
-
Rennes University HospitalUnknownMultiple Sclerosis, Relapsing-RemittingFrance
-
BayerCompletedMultiple SclerosisUnited States, Canada
-
Aaron BosterPfizer; EMD SeronoCompleted
-
BayerCompletedRelapsing Remitting MS (RRMS) | Secondary Progressive MS (SPMS)France, Germany, Korea, Republic of, Saudi Arabia, Spain, Taiwan, Czech Republic, Italy, Jordan, Lebanon, Turkey, Israel, Portugal, Netherlands, Iran, Islamic Republic of
-
BayerCompletedSecondary Progressive Multiple Sclerosis (SPMS) | Relapsing Remitting Multiple Sclerosis (RRMS)Portugal
-
Tehran University of Medical SciencesUnknownRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
NovartisCompletedMultiple SclerosisUnited States, Canada
-
Carmel Medical CenterTerminated
-
NovartisCompletedMultiple SclerosisUnited States, Turkey, Romania, United Kingdom, Poland, Austria, Canada, Australia
-
Tehran University of Medical SciencesUnknownRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
NovartisCompletedMultiple SclerosisGreece, Russian Federation, Switzerland, Germany, Israel, Ireland, Belgium, Finland, United Kingdom, Netherlands, Canada, Romania, Hungary, Poland, Czech Republic, Australia, Estonia, France, Slovakia, South Africa, Sweden, Turkey
-
NovartisCompletedRelapsing Multiple SclerosisBelgium, Poland, Spain, France, United Kingdom, Guatemala, Canada, Finland, Switzerland
-
BayerWithdrawnMultiple Sclerosis, Relapsing-RemittingKorea, Republic of
-
NovartisCompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)Relapsing-remitting Multiple SclerosisCanada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
-
GlaxoSmithKlineCompletedMultiple SclerosisItaly, Germany, Spain, United Kingdom, Australia, Netherlands, New Zealand, Russian Federation, France, Canada, Austria, Poland, Finland, Norway
-
Universita di VeronaCompletedRelapsing-remitting Multiple SclerosisItaly
-
John F. Foley, MDBiogenCompletedMultiple Sclerosis | RelapseUnited States
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingCanada
-
Rigshospitalet, DenmarkUniversity of Copenhagen; Statens Serum Institut; Copenhagen University Hospital... and other collaboratorsCompletedRelapsing Multiple SclerosisDenmark
-
Nelson Mandela Metropolitan UniversityUnknownMultiple Sclerosis, Relapsing-RemittingUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
UCB PharmaBiogenTerminatedMultiple SclerosisUnited States, France, Germany, Spain, Canada, Netherlands, Belgium, Hungary, Sweden, United Kingdom, Finland